Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-24-007096
Filing Date
2024-12-30
Accepted
2024-12-30 06:05:06
Documents
3
Period of Report
2024-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_123024.htm 6-K 41204
2 GRAPHIC logo.jpg GRAPHIC 12770
3 GRAPHIC hdr.jpg GRAPHIC 3120
  Complete submission text file 0001171843-24-007096.txt   64350
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filer) CIK: 0001114448 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-15024 | Film No.: 241586859
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)